Standard
Unique Aspects of Asthma in Women. / Tidemandsen, Casper; Halvard Hansen, Erik Soeren; Rasmussen, Soeren Malte; Ulrik, Charlotte Suppli; Backer, Vibeke.
In:
Clinics in Chest Medicine, Vol. 42, No. 3, 2021, p. 497-506.
Research output: Contribution to journal › Review › Research › peer-review
Harvard
Tidemandsen, C, Halvard Hansen, ES, Rasmussen, SM
, Ulrik, CS & Backer, V 2021, '
Unique Aspects of Asthma in Women',
Clinics in Chest Medicine, vol. 42, no. 3, pp. 497-506.
https://doi.org/10.1016/j.ccm.2021.04.009APA
Tidemandsen, C., Halvard Hansen, E. S., Rasmussen, S. M.
, Ulrik, C. S., & Backer, V. (2021).
Unique Aspects of Asthma in Women.
Clinics in Chest Medicine,
42(3), 497-506.
https://doi.org/10.1016/j.ccm.2021.04.009Vancouver
Author
Tidemandsen, Casper ; Halvard Hansen, Erik Soeren ; Rasmussen, Soeren Malte ; Ulrik, Charlotte Suppli ; Backer, Vibeke. / Unique Aspects of Asthma in Women. In: Clinics in Chest Medicine. 2021 ; Vol. 42, No. 3. pp. 497-506.
Bibtex
@article{521f5ab725114b8f9f85391b030ee0ec,
title = "Unique Aspects of Asthma in Women",
keywords = "Asthma, Clinical management, Estrogen, Fertility, Hormones, Pregnancy, Women",
author = "Casper Tidemandsen and {Halvard Hansen}, {Erik Soeren} and Rasmussen, {Soeren Malte} and Ulrik, {Charlotte Suppli} and Vibeke Backer",
note = "Funding Information: The Center for Physical Activity Research (CFAS) is supported by TrygFonden (grants ID 101390 and ID 20045 ). Funding Information: Dr ESH Hansen has no relevant conflicts of interest to declare. Dr C. Tidemandsen has no relevant conflicts of interest to declare. Dr SM Rasmussen has no relevant conflicts of interest to declare. Professor V. Backer has received an unrestricted grant for an asthma and fertility study by Novartis, has been part of advisory boards concerning asthma therapy by GSK, Teva, Chiesi, MSD, Novartis, AZ. Professor CS Ulrik has received personal fees for lectures, advisory board meetings, and so one, from AstraZeneca, Novartis, Chiesi, TEVA, GSK, ALK-Abello, Boehringer-Ingelheim, Mundipharma, Actelion, Orion Pharma, Sanofi and Mylan.The Center for Physical Activity Research (CFAS) is supported by TrygFonden (grants ID 101390 and ID 20045).",
year = "2021",
doi = "10.1016/j.ccm.2021.04.009",
language = "English",
volume = "42",
pages = "497--506",
journal = "Clinics in Chest Medicine",
issn = "0272-5231",
publisher = "W.B. Saunders Ltd",
number = "3",
}
RIS
TY - JOUR
T1 - Unique Aspects of Asthma in Women
AU - Tidemandsen, Casper
AU - Halvard Hansen, Erik Soeren
AU - Rasmussen, Soeren Malte
AU - Ulrik, Charlotte Suppli
AU - Backer, Vibeke
N1 - Funding Information:
The Center for Physical Activity Research (CFAS) is supported by TrygFonden (grants ID 101390 and ID 20045 ).
Funding Information:
Dr ESH Hansen has no relevant conflicts of interest to declare. Dr C. Tidemandsen has no relevant conflicts of interest to declare. Dr SM Rasmussen has no relevant conflicts of interest to declare. Professor V. Backer has received an unrestricted grant for an asthma and fertility study by Novartis, has been part of advisory boards concerning asthma therapy by GSK, Teva, Chiesi, MSD, Novartis, AZ. Professor CS Ulrik has received personal fees for lectures, advisory board meetings, and so one, from AstraZeneca, Novartis, Chiesi, TEVA, GSK, ALK-Abello, Boehringer-Ingelheim, Mundipharma, Actelion, Orion Pharma, Sanofi and Mylan.The Center for Physical Activity Research (CFAS) is supported by TrygFonden (grants ID 101390 and ID 20045).
PY - 2021
Y1 - 2021
KW - Asthma
KW - Clinical management
KW - Estrogen
KW - Fertility
KW - Hormones
KW - Pregnancy
KW - Women
U2 - 10.1016/j.ccm.2021.04.009
DO - 10.1016/j.ccm.2021.04.009
M3 - Review
C2 - 34353454
AN - SCOPUS:85111643523
VL - 42
SP - 497
EP - 506
JO - Clinics in Chest Medicine
JF - Clinics in Chest Medicine
SN - 0272-5231
IS - 3
ER -
